114 related articles for article (PubMed ID: 36974745)
1. Screening and characterisation of a novel efficient tumour cell-targeting peptide derived from insulin-like growth factor binding proteins.
He ML; Lei J; Cao XW; Zhao J; Wang FJ
J Drug Target; 2023 Jun; 31(5):500-510. PubMed ID: 36974745
[TBL] [Abstract][Full Text] [Related]
2. Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix.
Chen Y; Li S; Zhao J; Cao X; Wang F
J Drug Target; 2022 Mar; 30(3):326-333. PubMed ID: 34708678
[TBL] [Abstract][Full Text] [Related]
3. Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide.
Cao XW; Yang XZ; Du X; Fu LY; Zhang TZ; Shan HW; Zhao J; Wang FJ
J Drug Target; 2018 Nov; 26(9):777-792. PubMed ID: 29303375
[TBL] [Abstract][Full Text] [Related]
4. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-tumor activity of trichosanthin after combination with a human-derived cell-penetrating peptide, and a possible mechanism of activity.
Lu YZ; Li PF; Li YZ; Luo F; Guo C; Lin B; Cao XW; Zhao J; Wang FJ
Fitoterapia; 2016 Jul; 112():183-90. PubMed ID: 27050721
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
7. Design and characterization of a novel tumor-homing cell-penetrating peptide for drug delivery in TGFBR3 high-expressing tumors.
Wu YJ; Lei J; Zhao J; Cao XW; Wang FJ
Chem Biol Drug Des; 2023 Dec; 102(6):1421-1434. PubMed ID: 37620132
[TBL] [Abstract][Full Text] [Related]
8. Constructing a better binding peptide for drug delivery targeting the interleukin-4 receptor.
Bai XD; Cao XW; Chen YH; Fu LY; Zhao J; Wang FJ
J Drug Target; 2020 Nov; 28(9):970-981. PubMed ID: 32363946
[TBL] [Abstract][Full Text] [Related]
9. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
10. The heparin-binding domain of HB-EGF as an efficient cell-penetrating peptide for drug delivery.
Luo Z; Cao XW; Li C; Wu MD; Yang XZ; Zhao J; Wang FJ
J Pept Sci; 2016 Nov; 22(11-12):689-699. PubMed ID: 27739168
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.
Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ
J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361
[TBL] [Abstract][Full Text] [Related]
12. A novel trichosanthin fusion protein with increased cytotoxicity to tumor cells.
Lin B; Yang XZ; Cao XW; Zhang TZ; Wang FJ; Zhao J
Biotechnol Lett; 2017 Jan; 39(1):71-78. PubMed ID: 27714558
[TBL] [Abstract][Full Text] [Related]
13. Screening and characterization of a novel high-efficiency tumor-homing cell-penetrating peptide from the buffalo cathelicidin family.
Xu YY; Cao XW; Fu LY; Zhang TZ; Wang FJ; Zhao J
J Pept Sci; 2019 Sep; 25(9):e3201. PubMed ID: 31309656
[TBL] [Abstract][Full Text] [Related]
14. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
15. Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide.
Kim A; Shin TH; Shin SM; Pham CD; Choi DK; Kwon MH; Kim YS
PLoS One; 2012; 7(12):e51813. PubMed ID: 23251631
[TBL] [Abstract][Full Text] [Related]
16. A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells.
Lim KJ; Sung BH; Shin JR; Lee YW; Kim DJ; Yang KS; Kim SC
PLoS One; 2013; 8(6):e66084. PubMed ID: 23776609
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery.
Upadhya A; Sangave PC
J Pept Sci; 2016 Oct; 22(10):647-659. PubMed ID: 27723187
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb.
Russo VC; Bach LA; Fosang AJ; Baker NL; Werther GA
Endocrinology; 1997 Nov; 138(11):4858-67. PubMed ID: 9348216
[TBL] [Abstract][Full Text] [Related]
19. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
20. Highly Efficient Delivery of Functional Cargoes by a Novel Cell-Penetrating Peptide Derived from SP140-Like Protein.
Wang H; Ma J; Yang Y; Zeng F; Liu C
Bioconjug Chem; 2016 May; 27(5):1373-81. PubMed ID: 27070736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
